Enanta Pharmaceuticals: Peers

The FY2025 (Sep) proxy of Enanta Pharmaceuticals names 21 peer companies for pay. Among Enanta Pharmaceuticals and these peers, CEO pay was 8th highest of 11 and total shareholder return was 8th highest of 11.

8th highest of 11in Enanta Pharmaceuticals and its pay peers, FY2025 (Sep) by CEO pay:

$1.4M$8.5M

8th highest of 11in Enanta Pharmaceuticals and its pay peers, FY2025 (Sep) by total shareholder return:

$9$206

Pay peer group, FY2025 (Sep) proxy

Travere Therapeutics
Altimmune
Nektar Therapeutics
Rigel Pharmaceuticals
Regenxbio
Vanda Pharmaceuticals
Lexicon Pharmaceuticals
Editas Medicine
Inovio Pharmaceuticals
Arbutus Biopharma
Allogene TherapeuticsNot disclosedNot disclosed
Arcturus Therapeutics HoldingsNot disclosedNot disclosed
Heron TherapeuticsNot disclosedNot disclosed
Karyopharm TherapeuticsNot disclosedNot disclosed
MacrogenicsNot disclosedNot disclosed
OmerosNot disclosedNot disclosed
Puma BiotechnologyNot disclosedNot disclosed
Sage TherapeuticsNot disclosedNot disclosed
Sangamo PharmaceuticalsNot disclosedNot disclosed
Sutro BiopharmaNot disclosedNot disclosed
Theravance BiopharmaNot disclosedNot disclosed
21 companies

Changes by year

FY2025 (Sep) proxy

  • AddedAllogene Therapeuticspay peer group
  • AddedAltimmunepay peer group
  • AddedEditas Medicinepay peer group
  • AddedInovio Pharmaceuticalspay peer group
  • AddedNektar Therapeuticspay peer group
  • AddedPuma Biotechnologypay peer group
  • AddedRigel Pharmaceuticalspay peer group
  • AddedSage Therapeuticspay peer group
  • AddedSutro Biopharmapay peer group
  • RemovedAgiospay peer groupbecause they had been acquired
  • RemovedAllovirpay peer groupbecause they had been acquired
  • RemovedBioCrystpay peer groupbecause they had been acquired
  • RemovedDecipherapay peer groupbecause they had been acquired
  • RemovedFibroGenpay peer groupbecause they had been acquired
  • RemovedInterceptpay peer groupbecause they had been acquired
  • RemovedLigandpay peer groupbecause they had been acquired
  • RemovedSupernuspay peer groupbecause they had been acquired
  • RemovedXencorpay peer groupbecause they had been acquired

FY2024 (Sep) proxy

  • AddedArcturuspay peer group
  • AddedLexiconpay peer group
  • RemovedAmicus Therapeuticspay peer groupdue to their being outside of our market capitalization or revenue criteria
  • RemovedCorcept Therapeuticspay peer groupdue to their being outside of our market capitalization or revenue criteria
  • RemovedImmunoGenpay peer groupdue to their being outside of our market capitalization or revenue criteria
  • RemovedINSMEDpay peer groupdue to their being outside of our market capitalization or revenue criteria
  • RemovedMadrigal Pharmaceuticalspay peer groupdue to their being outside of our market capitalization or revenue criteria
  • RemovedPTC Therapeuticspay peer groupdue to their being outside of our market capitalization or revenue criteria
  • RemovedVir Biotechnologypay peer groupdue to their being outside of our market capitalization or revenue criteria

FY2023 (Sep) proxy

  • AddedAllovirpay peer groupBased on the revised criteria, our Compensation Committee added Allovir, Arbutus Biopharma, Arcturus Therapeutics, Deciphera Pharmaceuticals, MacroGenics and Omeros to our peer group for 2023
  • AddedArbutus Biopharmapay peer groupBased on the revised criteria, our Compensation Committee added Allovir, Arbutus Biopharma, Arcturus Therapeutics, Deciphera Pharmaceuticals, MacroGenics and Omeros to our peer group for 2023
  • AddedArcturus Therapeutics Holdingspay peer groupBased on the revised criteria, our Compensation Committee added Allovir, Arbutus Biopharma, Arcturus Therapeutics, Deciphera Pharmaceuticals, MacroGenics and Omeros to our peer group for 2023
  • AddedDeciphera Pharmaceuticalspay peer groupBased on the revised criteria, our Compensation Committee added Allovir, Arbutus Biopharma, Arcturus Therapeutics, Deciphera Pharmaceuticals, MacroGenics and Omeros to our peer group for 2023

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.